Asian markets ended mixed on Wednesday as investors booked profits after record November, while optimism surrounding Covid-19 vaccines after the European Medicines Agency said it received applications for emergency approval of vaccines developed by Pfizer with BioNTech and Moderna kept market sentiment well supported. Also helping sentiment, a bipartisan group of US legislators unveiled a $908 billion Covid-19 relief bill on Tuesday. Japanese shares ended almost flat despite hopes for economic recovery if vaccines are rolled out fast.
Asian Indices | Last Trade | Change in Points | Change in % |
Shanghai Composite | 3,449.38 | -2.56 | -0.07 |
Hang Seng | 26,532.58 | -35.10 | -0.13 |
Jakarta Composite | 5,813.99 | 89.25 | 1.56 |
KLSE Composite | 1,598.72 | -3.54 | -0.22 |
Nikkei 225 | 26,800.98 | 13.44 | 0.05 |
Straits Times | 2,810.95 | -3.17 | -0.11 |
KOSPI Composite | 2,675.90 | 41.65 | 1.58 |
Taiwan Weighted | 13,989.14 | 103.47 | 0.75 |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: